CBD Life Sciences plans to acquire two New York cannabis dispensaries for $14M to boost market presence in the $4.2B NY cannabis market by 2027.

CBD Life Sciences, Inc., a leading CBD company, plans to acquire strategic interests in two New York cannabis dispensaries with a combined value of $14M. The acquisitions aim to boost the company's market presence and profitability in the rapidly growing $4.2B New York cannabis market by 2027. These moves align with CBD Life Sciences' growth strategy of expanding in key markets, increasing revenue streams, and enhancing profitability.

August 27, 2024
110 Articles